Tivozanib Has Efficacy in Advanced Renal Cell Carcinoma Post-ICI Therapy

FRIDAY, Sept. 20, 2024-- For patients with metastatic renal cell carcinoma (mRCC) and progression during or after one to two prior lines of therapy, including one immune checkpoint inhibitor (ICI), tivozanib has efficacy, according to a study...